Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-28

Clinical Trial Update: A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study

View source ↗

Summary

A completed prospective observational study assessing whether a combination of Coenzyme Q10, feverfew, and magnesium may help in migraine prophylaxis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)
  • Feverfew (feverfew)
  • Magnesium (magnesium)

Snippet

Sponsor: PiLeJe | Conditions: Migraine | Status: COMPLETED